The Board of Directors of Guangdong Hybribio Biotech Co.,Ltd. has authorized a buyback plan on June 27, 2024.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 CNY | -0.84% |
|
+3.97% | -49.57% |
06-27 | Guangdong Hybribio Biotech Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. | CI |
06-27 | Guangdong Hybribio Biotech Co.,Ltd. authorizes a Buyback Plan. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.57% | 419M | |
-10.29% | 11.38B | |
-20.75% | 6.83B | |
+5.45% | 5.52B | |
+28.32% | 5.44B | |
-21.94% | 3.62B | |
+6.32% | 2.56B | |
-66.49% | 2.26B | |
+30.36% | 2.24B | |
-12.28% | 2.13B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Guangdong Hybribio Biotech Co.,Ltd. authorizes a Buyback Plan.